Transaction · 0001813798-26-000017

Wassil Jim

Wassil Jim, COO, reported a transaction classified as exercise at Vaxcyte, Inc. involving 2250.000000 shares for an estimated $0.00. Reported holdings after the transaction were 66648.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MCOO

PCVXVaxcyte, Inc.

Trade date: Sep 01, 2026
Filing date: Sep 02, 2026

View on SEC Insider profile

Estimated value$0Shares × reported price

Shares traded2.25k$0.00 per share

Holdings after66.6kDirect

% of reported position tradedUnavailableThis security and ownership context

How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

PCVX price since this filing

Daily closing prices, with the filing date and available return windows

PCVX · Daily closing priceLoading daily prices…

Filing dateReturn windows appear as prices become available.

Pre-filing1mo ago -13.6%1w ago +0.0%1d ago +0.0%

Returns since7d -4.9%30d -9.7%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative

Type: exercise
Identifier: 0001813798-26-000017
Transaction date: Sep 01, 2026
Shares: 2,250 sh
Estimated value: $0
Holdings after: 66,648 sh

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M

Derivative Transaction Direct Ownership 10b5-1 Detected

Filing-only score

-16 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated

direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake.
timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction.
derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.

Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CHIEF OPERATING OFFICER

Officer YesDirector No10% NoOther No

Footnotes & amended

F1
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
F2
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.
F3
The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.275. The reporting person will provide upon request to the SEC, the issuer or security holder…
(4 footnotes)
issuer, full information regarding the number of shares sold at each separate price.
F4
The price reported is a weighted-average price. The shares were sold at prices ranging from $61.31 to $62.04. The reporting person will provide upon request to the SEC, the issuer or security holder o…
F5
The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.22. The reporting person will provide upon request to the SEC, the issuer or security holder o…
F6
The price reported is a weighted-average price. The shares were sold at prices ranging from $61.34 to $61.48. The reporting person will provide upon request to the SEC, the issuer or security holder o…
F7
Stock Option is fully vested and exercisable.

Original filing · 0001813798-26-000017

Related transactions

0 other transactions

Same SEC filing

Recent company activity

0 recent txs

PCVX